Activating Transcription Factor 3 is a Molecular Target for Apoptotic Effect of Silymarin in Human Colorectal Cancer Cells
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Apoptosis has been regarded as a therapeutic target because apoptosis is typically disturbed in human cancer. Silymarin found in the seeds of the milk thistle (Silybum marianum) has been reported to exert anti-cancer properties through apoptosis. This study was performed to investigate the molecular target for silymarin-mediated apoptosis in human colorectal cancer cells. Silymarin reduced the cell viability and induced an apoptosis in human colorectal cancer cells. ATF3 overexpression increased PARP cleavage by silymarin. Increased ATF3 expression in both protein and mRNA was observed in silymarin-treated cells. In addition, silymarin increased the luciferase activity of ATF3 promoter. Inhibition of JNK and IκK-α blocked silymarin-mediated ATF3 expression. The results suggest that silymarin induces apoptosis through JNK and IκKα-dependent ATF3 expression in human colorectal cancer cells. Key words - Silymarin, Activating transcription factor 3, Apoptosis, Human colorectal cancer, Cancer chemoprevention
Abstract
Apoptosis has been regarded as a therapeutic target because apoptosis is typically disturbed in human cancer. Silymarin found in the seeds of the milk thistle (Silybum marianum) has been reported to exert anti-cancer properties through apoptosis. This study was performed to investigate the molecular target for silymarin-mediated apoptosis in human colorectal cancer cells. Silymarin reduced the cell viability and induced an apoptosis in human colorectal cancer cells. ATF3 overexpression increased PARP cleavage by silymarin. Increased ATF3 expression in both protein and mRNA was observed in silymarin-treated cells. In addition, silymarin increased the luciferase activity of ATF3 promoter. Inhibition of JNK and IκK-α blocked silymarin-mediated ATF3 expression. The results suggest that silymarin induces apoptosis through JNK and IκKα-dependent ATF3 expression in human colorectal cancer cells. Key words - Silymarin, Activating transcription factor 3, Apoptosis, Human colorectal cancer, Cancer chemoprevention
참고문헌 (24)
- Abenavoli, L., "Milk thistle in liver diseases : past, present, future", Phytother. Res, 24, pp.1423~1432 (2010)
- Baek, S. J., "Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells", Carcinogenesis, 25, pp.2425~2432 (2004)
- Cai, Y., "Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells : activation of c-Jun NH(2)-terminal kinase and promoter response element", Blood, 96, pp.2140~2148 (2000)
- Chen, H. H., "Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells", Mol. Pharmacol, 65, pp.1130~1140 (2004)
- Das, S., "Meaningful use of electronic health records in otolaryngology : recommendations from the American Academy of Otolaryngology-Head and Neck Surgery Medical Informatics Committee. Otolaryngol", Head Neck Surg, 144, pp.135~141 (2011)
- Edagawa, M., "Role of activating transcription factor 3(ATF3)in endoplasmic reticulum(ER)stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor(TNF)-related apoptosis-inducing ligand(TRAIL)-mediated apoptosis through up-regulation of death receptor 5(DR5)by zerumbone and celecoxib", J. Biol. Chem, 289, pp.21544~21561 (2014)
- Eo, H. J., "Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells", Int. Immunopharmacol, 24, pp.1~6 (2015)
- Fulda, S., "Targeting extrinsic apoptosis in cancer : Challenges and opportunities", Semin. Cell Dev. Biol, 39, pp.20~25 (2015)
- Jiang, X., "Potential Dual Role of Activating Transcription Factor 3 in Colorectal Cancer", Anticancer Res, 36, pp.509~516 (2016)
- Lee, S. H., "Indole-3-carbinol and 3, 3’-diindolylmethane induce expression of NAG-1 in a p53-independent manner", Biochem. Biophys. Res. Commun, 328, pp.63~69 (2005)
- Lee, S. H., "3, 3’-diindolylmethane induces activating transcription factor 3(ATF3)via ATF4 in human colorectal cancer cells", J. Nutr. Biochem, 24, pp.664~671 (2013)
- Lee, S. H., "Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner", Carcinogenesis, 27, pp.972~981 (2006)
- Liang, G., "ATF3 gene. Genomic organization, promoter, and regulation", J. Biol. Chem, 271, pp.1695~1701 (1996)
- Liu, J., "Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells", Biochem. Biophys. Res. Commun, 445, pp.320~326 (2014)
- Lockshin, R. A., "Cell death in health and disease", J. Cell. Mol. Med, 11, pp.1214~1224 (2007)
- Mereish, K. A., "Protection against microcystin-LR-induced hepatotoxicity by Silymarin : biochemistry, histopathology, and lethality", Pharmaceut. Res, 8, pp.273~277 (1991)
- Pan, M. H., "Food bioactives, apoptosis, and cancer", Mol. Nutr. Food Res, 52, pp.43~52 (2008)
- Pan, M. H., "Chemopreventive effects of natural dietary compounds on cancer development", Chem. Soc. Rev, 37, pp.2558~2574 (2008)
- Ramasamy, K., "Multitargeted therapy of cancer by silymarin", Cancer Lett, 269, pp.352~362 (2008)
- Taketani, K., "Key role of ATF3 in p53-dependent DR5induction upon DNA damage of human colon cancer cells", Oncogene, 31, pp.2210~2221 (2012)
- Yamaguchi, K., "Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway", Cancer Res, 66, pp.2376~2384 (2006)
- Yan, C., "Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination", EMBO J, 24, pp.2425~2435 (2005)
- Zhong, X., "Silymarin causes caspases activation and apoptosis in K562leukemia cells through inactivation of Akt pathway", Toxicology, 227, pp.211~216 (2006)
- Zi, X., "Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468, induction of G1 arrest through an increase in Cip1", p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins, 1998, pp.4, 1099~1064